본문 바로가기
KERD
논문

염화벤잘코늄(Benzalkonium chloride) 살균제의 용도 및 건강 위험에 대한 고찰 -가습기 살균제를 중심으로

A Review on the Health Risks Associated with the Use of Products Containing Benzalkonium Chloride (BKC), Focusing on Humidifier Disinfectant Products

김하나|박동욱|조경이|김지원
한국환경보건학회 (Korean Society of Environmental Health)|2021.12|한국환경보건학회지 (JOURNAL OF ENVIRONMENTAL HEALTH SCIENCES)|제47권 제6호|pp. 513-520|DOI 10.5668/JEHS.2021.47.6.513

1

조회

0

다운로드

4

인용

0

참고문헌

키워드

contact dermatitisasthmahumidifier disinfectantBenzalkonium chloride (BKC)

초록

Background: Benzalkonium chloride (BKC) has been extensively used as a preservative in industrial products and in hygiene, medical, and cosmetic applications. Humidifier disinfectant (HD) products containing BKC have been used in South Korea. Objectives: This study was aimed to review types of products containing BKC, to summarize the regulations in the US, EU, Japan, and South Korea, and to review the health effects associated with the use of HD. Methods: We reviewed and summarized documents which were searched through PubMed and Google Scholar with the key words: BKC and asthma/contact dermatitis, humidifier disinfectant-associated lung injury (HDLI), and more. Results: Regulations in most countries including South Korea do not allow its use as disinfectants in spray- type of products for medicine, cosmetics, and household products. Two types of HD containing BKC (800~1,270 ppm) were marketed in South Korea from 1996~2003. Health effects reported from people who used products containing BKC were allergic contact dermatitis, erythema, and respiratory disease, including asthma. Two people who responded as HD users containing BKC only were confirmed to have developed asthma. HD-associated lung injury (HDLI) was reported by consumers who used both HD containing polyhexamethylene guanidine (PHMG) and HD containing BKC. Conclusions: In conclusion, the use of BKC as a biocide has to be controlled considering the route and pattern of exposure. Products containing BKC as preservatives were reviewed with exposure routes and sites in the human body such as skin, eyes, and the respiratory tract. HD containing BKC was clinically evaluated to be associated with asthma.

Abstract

Background: Benzalkonium chloride (BKC) has been extensively used as a preservative in industrial products and in hygiene, medical, and cosmetic applications. Humidifier disinfectant (HD) products containing BKC have been used in South Korea. Objectives: This study was aimed to review types of products containing BKC, to summarize the regulations in the US, EU, Japan, and South Korea, and to review the health effects associated with the use of HD. Methods: We reviewed and summarized documents which were searched through PubMed and Google Scholar with the key words: BKC and asthma/contact dermatitis, humidifier disinfectant-associated lung injury (HDLI), and more. Results: Regulations in most countries including South Korea do not allow its use as disinfectants in spray- type of products for medicine, cosmetics, and household products. Two types of HD containing BKC (800~1,270 ppm) were marketed in South Korea from 1996~2003. Health effects reported from people who used products containing BKC were allergic contact dermatitis, erythema, and respiratory disease, including asthma. Two people who responded as HD users containing BKC only were confirmed to have developed asthma. HD-associated lung injury (HDLI) was reported by consumers who used both HD containing polyhexamethylene guanidine (PHMG) and HD containing BKC. Conclusions: In conclusion, the use of BKC as a biocide has to be controlled considering the route and pattern of exposure. Products containing BKC as preservatives were reviewed with exposure routes and sites in the human body such as skin, eyes, and the respiratory tract. HD containing BKC was clinically evaluated to be associated with asthma.

참고문헌 (49)

  1. 박동욱, "가습기 살균제 제품의 건강위험 고찰 - 제품 수와 살균제 성분을 중심으로 -", 한국환경보건학회지, 46(5), pp.481~494 (2020), 한국환경보건학회
  2. "Comprehensive Supporting Portal for Humidifier Disinfectant Victims: Statistical Data"[URL]
  3. Park DU, "Association of high-level humidifier disinfectant exposure with lung injury in preschool children", Sci Total Environ, 616-617, pp.855~862 (2018)
  4. Purohit A, "Quaternary ammonium compounds and occupational asthma", Int Arch Occup Environ Health, 73(6), pp.423~427 (2000)
  5. United States. Environmental Protection Agency, "Reregistration Eligibility Decision for Alkyl Dimethyl Benzyl Ammonium Chloride (ADBAC)" (2006), Environmental Protection Agency
  6. Choi SM, "Risk assessment of benzalkonium chloride in cosmetic products", J Toxicol Environ Health B Crit Rev, 21(1), pp.8~23 (2018)
  7. European Union, "Biocidal Products Regulation" (2012), European Parliament, Council of the European Union
  8. "Commission Implementing Decision (EU)2016/1950 of 4 November 2016 on the Non-Approval of Certain Biocidal Active Substances Pursuant to Regulation (EU) No 528/2012of the European Parliament and of the Council"[URL]
  9. "Regulation (EU) 528/2012- Annex V: List of Preservatives Allowed in Cosmetic Products"[URL]
  10. "Regulation (EC) No. 1223/2009 on Cosmetic Products - Annex III"[URL]
  11. Cosmetic Ingredient Review Expert Panel, "Annual review of cosmetic ingredient safety assessments : 2005", 2006, 2008, pp.27, 77~142
  12. US Food and Drug Administration, "Safety and effectiveness of health care antiseptics; topical antimicrobial drug products for over-the-counter human use. Final rule", Fed Regist, 82(242), pp.60474~60503 (2017)
  13. Japan Ministry of Health and Welfare, "Standards for Cosmetics, Notification No.331", Ministry of Health and Welfare, ~ (2000)
  14. "Regulations on Safety Standards for Cosmetics. No. 2020-12 (Amended on Feb 25, 2020)"[URL]
  15. "Korean Manufacturing Standard for Medicine. No.2021-68 (Partly Amended and Enforced on August 9, 2021)"[URL]
  16. "Prior Notice 1: Modification Order for Approving Drugs Containing Benzalkonium Chlorides"[URL]
  17. "Prior Notice 2: Modification Order for Approving Drugs Containing Benzalkonium Chlorides"[URL]
  18. "Standard for Consumer Chemical Products Designated as Products Subject to Safety Confirmation and their Safety and Labeling No.2021-150 (Partly Amended and Enforced on July 30, 2021)"[URL]
  19. Lewis RJ, "Sax's Dangerous Properties of Industrial Materials" (2012), Wiley-Blackwell
  20. Willis CM, "Experimentally-induced irritant contact dermatitis. Determination of optimum irritant concentrations", Contact Dermatitis, 18(1), pp.20~24 (1988)
  21. Dao H Jr, "Sensitization prevalence for benzalkonium chloride and benzethonium chloride", Dermatitis, 23(4), pp.162~166 (2012)
  22. Fisher AA, "Allergic contact dermatitis and conjunctivitis from benzalkonium chloride", Cutis, 39(5), pp.381~383 (1987)
  23. Suneja T, "Occupational dermatoses in health care workers evaluated for suspected allergic contact dermatitis", Contact Dermatitis, 58(5), pp.285~290 (2008)
  24. Stanford D, "Allergic contact dermatitis from benzalkonium chloride in plaster of Paris", Contact Dermatitis, 35(6), pp.371~372 (1996)
  25. Isaac J, "Benzalkonium chloride : an irritant and sensitizer", Dermatitis, 28(6), pp.346~352 (2017)
  26. Oiso N, "Irritant contact dermatitis from benzalkonium chloride in shampoo", Contact Dermatitis, 52(1), pp.54~ (2005)
  27. Tartari F, "Allergic contact dermatitis to benzalkonium chloride with erythema multiforme-like reaction in a child", Contact Dermatitis, 82(6), pp.397~399 (2020)
  28. Ling T, "Irritant reactions to an antiseptic bath emollient", J Dermatol Treat, 11(4), pp.263~267 (2000)
  29. Krogsrud NE, "Airborne irritant contact dermatitis from benzalkonium chloride", Contact Dermatitis, 36(2), pp.112~ (1997)
  30. Mauleón C, "Airborne contact dermatitis from n-alkyl dimethylbenzylammonium chloride and n-alkyl dimethylethyl-benzylammonium chloride in a detergent", Contact Dermatitis, 55(5), pp.311~312 (2006)
  31. Freeman PD, "Preservatives in topical ophthalmic medications : historical and clinical perspectives", Expert Rev Ophthalmol, 4(1), pp.59~64 (2009)
  32. Lee J, "Glaucoma and ocular surface disease", J Korean Glaucoma Soc, 8(1), pp.33~35 (2019)
  33. Rasmussen CA, "Benzalkonium chloride and glaucoma", J Ocul Pharmacol Ther, 30(2-3), pp.163~169 (2014)
  34. Yu I, "Medical treatment of glaucoma and ocular surface disease : from old to new", J Korean Glaucoma Soc, 6(1), pp.30~33 (2017)
  35. Orsini D, "Allergic contact dermatitis to dorzolamide and benzalkonium chloride", Postepy Dermatol Alergol, 35(5), pp.538~539 (2018)
  36. Lee SJ, "Allergic contact dermatitis caused by dorzolamide eyedrops", Clin Ophthalmol, 9, pp.575~577 (2015)
  37. Datta S, "The eye drop preservative benzalkonium chloride potently induces mitochondrial dysfunction and preferentially affects LHON mutant cells", Invest Ophthalmol Vis Sci, 58(4), pp.2406~2412 (2017)
  38. Suzuki K, "Safety and efficacy of benzalkonium chloride-optimized tafluprost in Japanese glaucoma patients with existing superficial punctate keratitis", J Glaucoma, 24(6), pp.e145~e150 (2015)
  39. Sezgin Akçay Bİ, "Effects of polyquaternium-and benzalkonium-chloridepreserved travoprost on ocular surfaces : an impression cytology study", J Ocul Pharmacol Ther, 30(7), pp.548~553 (2014)
  40. Cha SH, "Corneal epithelial cellular dysfunction from benzalkonium chloride(BAC)in vitro", Clin Exp Ophthalmol, 32(2), pp.180~184 (2004)
  41. George M, "Paradoxical bronchospasm from benzalkonium chloride (BAC) preservative in albuterol nebulizer solution in a patient with acute severe asthma. A case report and literature review of airway effects of BAC", Respir Med Case Rep, 21, pp.39~41 (2017)
  42. Byoung Hoon Lee, "Benzalkonium Chloride Induced Bronchoconstriction in Patients with Stable Bronchial Asthma", The Korean Journal of Internal Medicine, 22(4), pp.244~248 (2007), 대한내과학회
  43. Graf P, "Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis", Arch Otolaryngol Head Neck Surg, 125(10), pp.1128~1132 (1999)
  44. Lechien JR, "Contact allergy to benzalkonium chloride in patients using a steroid nasal spray: a report of 3 cases", Ear Nose Throat J, 97(1-2), pp.E20~E22 (2018)
  45. Vandenplas O, "Asthma related to cleaning agents : a clinical insight", BMJ Open, 3(9), pp.e003568~ (2013)
  46. "Quaternary Ammonium Compounds in Cleaning Products: Health &Safety Information for Cleaners and Supervisors"[URL]
  47. Park DU, "Analysis of Components of Disinfectant Contained in Humidifier Disinfectant Products" (2020), Special Committee for Examining the Cause of Tragedy caused by Humidifier Disinfectant
  48. "Study on the Respiratory Toxicity of Biocide, Benzalknonium Chloride"[URL]
  49. Johnson NF, "Pulmonary toxicity of benzalkonium chloride", J Aerosol Med Pulm Drug Deliv, 31(1), pp.1~17 (2018)

관련 논문AI추천

가습기 살균제 제품의 건강위험 고찰 - 제품 수와 살균제 성분을 중심으로 -김소연, 김지원, 박동욱, 박지훈, 이승희, 임흥규, 조경이한국환경보건학회 · 한국환경보건학회지2020 · 제46권 제5호Chloromethylisothiazolinone (CMIT)과 Methylisothiazolinone (MIT)의 건강영향에 대한 고찰 - 가습기 살균제 폐 손상을 중심으로 -권정환, 김지원, 류승훈, 박동욱, 박소영, 박지훈, 이소연한국환경보건학회 · 한국환경보건학회지2020 · 제46권 제3호가습기 살균제 참사와 관련된 당시 생활화학물질 관리 법령에 대한 비판적 고찰박동욱, 박태현, 조경이, 조대환, 최예용한국환경보건학회 · 한국환경보건학회지2022 · 제48권 제3호가습기살균제 피해사건과 교훈백도명, 임신예, 임홍규, 최예용한국환경보건학회 · 한국환경보건학회지2012 · 제38권 제02호CMIT/MIT 함유 가습기 살균제 제품의 제조 및 판매기업 형사판결 1심 재판 판결문에 대한 과학적 고찰 (I) - 제품 위험성과 노출평가 측면에서권정환, 김성균, 김지원, 박동욱, 전형배, 조경이, 최상준한국환경보건학회 · 한국환경보건학회지2021 · 제47권 제2호가습기 살균제 폐 손상 피해자의 살균제 노출 특성 -태아와 임산부 노출을 중심으로 -이은, 김선경, 노현석, 도경현, 류승훈, 박동욱, 배문주, 백도명, 신동천, 안종주, 임흥규, 조재림, 차원석, 최예용, 홍상범, 홍수종한국환경보건학회 · 한국환경보건학회지2016 · 제42권 제3호

이 간행물의 다른 논문 (5건)

환경성질환과 환경유해인자의 연관성을 규명하기 위한 독성 연구 고찰지경희, 가유진pp. 505-512서울시 구로구에서 COVID-19 발생 전ㆍ후 초미세먼지(PM2.5) 농도 변화에 따른 인구집단 노출평가민기홍, 최길용, 김동준, 신준섭, 최영태, 조만수, 최윤형, 양원호, 이채관, 우재민, 김동준, 성경화, 신정현pp. 521-529폐금속광산 지역 주민의 비소 대사에 영향을 미치는 MTHFR, As3MT, GSTO1 유전자 다형성울지, 홍영습, 조성식, 김기환, 김권민, 김병권, 손현진, 임현주, 권정연pp. 530-539Polydopamine (PDA)-TiO2 코팅 유리섬유 직물을 이용한 VOCs의 저감 성능 및 항균성 연구박서현, 박찬규, 이홍주, 최예인pp. 540-547피톤치드(모노테르펜) 농도 예측을 위한 회귀분석 기반 모델식 -춘천 수리봉을 중심으로-이건호, 이영섭, 김병욱, 김재철, 김대열, 현근우, 고영훈, 홍영균, 이석종, 양승표pp. 548-557
원문 보기